세계 백신 기술 시장 규모는 2023년 450억 달러로 평가되었고 예측 기간 동안 복합 연간 성장률(CAGR) 7.8%를 나타낼 전망이며 2028년 말에는 653억 달러 규모로 성장할 것으로 예측됩니다.
서브유닛, 유전자 재조합, 다당류, 결합형 백신의 부문은 2023년 235억 달러에서 동기간 중 복합 연간 성장률(CAGR) 7.9%를 나타낼 전망이며 2028년에는 344억 달러 규모로 성장할 것으로 예측됩니다. 또한 약독화 백신 부문은 2023년 84억 달러에서 성장을 지속하여 복합 연간 성장률(CAGR) 7.6%를 나타낼 전망이며 2028년에는 121억 달러 규모로 성장할 것으로 예측됩니다.
이 보고서는 세계 백신 기술 시장을 조사했으며, 시장 및 기술 배경, 시장 영향요인 분석, 시장 규모 추이 및 예측, 각종 구분 및 지역별 상세 분석, 기술 동향, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 요약 및 하이라이트
제3장 시장 및 기술 배경
- 정의
- 면역계와 백신
- 면역 시스템의 구성 요소
- 면역계의 세포
- 면역반응
- 주요 조직 적합성 복합체(MHC)
- 예방접종과 백신
- 면역계의 장애
- 라이프 스타일이 면역 시스템에 미치는 영향
- 백신의 구조
- 예방접종의 원칙
- 면역의 유형
- 예방접종의 장점
- 백신의 역사
- 백신과 예방접종, 개요
- 백신의 유형
- 약독화(생) 백신
- 불활성화(사멸) 백신
- 톡소이드 백신
- 서브 유닛 백신
- 결합형 백신
- 재조합 벡터 백신
- DNA 백신
- RNA 백신
- 면역
- 예방접종의 장점
- 보조제 및 부형제
- 병원체의 성분
- 미립자 보조제
- 백신으로 예방할 수 있는 감염증
- 인간의 질병
- 바이러스성 질환
- 세균성 질환
- 규제 측면
- 세계보건기구(WHO) 인증된 백신
- 신제품 승인
- 리콜
- 백신에서 중요한 규제의 진전
제4장 시장 역학
- 개요
- 시장 성장 촉진요인
- 예방접종에 대한 의식의 고조
- 투자와 연구개발 확대
- 새로운 백신
- 감염증의 유행
- 시장 성장 억제요인
- 백신 개발 및 가격 설정
- 시장 기회
- 신흥 시장에서의 수요 증가
- 치료용 백신
제5장 COVID-19 백신 세계 시장
- 개요
- COVID-19 백신 기술
- mRNA 기술의 등장
- COVID-19에 의한 유아의 정기 예방접종에 대한 영향
- COVID-19에 의한 혼란
- 세계 커버율의 정체
- 국가, 지역별 진척과 과제
제6장 시장 분석 : 기술별
- 세계 백신 기술 시장 :기술별
- 서브유닛, 재조합, 다당류, 복합체 백신
- 약독화 생백신
- 불활성화 백신
- 톡소이드 백신
- 기타/혼합 백신
제7장 시장 분석 : 질환별
- 세계 백신 기술 시장 :질환별
- 폐렴구균
- 디프테리아와 파상풍
- HPV
- MMR
- 기타
제8장 시장 분석 : 연령층별
- 세계 백신 기술 시장 :연령층별
- 소아
- 청소년기?성인
제9장 시장 분석 : 지역별
- 세계 백신 기술 시장 :지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제10장 새로운 기술과 개발
- 개발 상황
- mRNA 백신
- 바이러스 벡터 백신
- 나노입자 백신
- DNA 백신
- 바이러스 유사 입자(VLP) 백신
- 자기 증폭 RNA 백신
- 혁신적인 애주번트
- AI 및 계산 생물학
- 개별화 백신
- 식물 기반 백신
제11장 경쟁 구도
제12장 기업 프로파일
- ABBOTT
- ASTRAZENECA
- BAVARIAN NORDIC
- BHARAT BIOTECH INTERNATIONAL LTD.
- EMERGENT BIOSOLUTIONS INC.
- GSK PLC.
- JOHNSON & JOHNSON SERVICES INC.
- MERCK & CO. INC.
- MITSUBISHI TANABE PHARMA CORP.
- PANACEA BIOTEC LTD.
- PFIZER INC.
- SANOFI
제13장 부록: 약어 목록
BJH
Highlights:
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
The global market for subunit, recombinant, polysaccharide, and conjugate vaccines is expected to grow from $23.5 billion in 2023 to $34.4 billion by 2028, at a CAGR of 7.9% from 2023 to 2028.
The global market for live-attenuated vaccines is expected to grow from $8.4 billion in 2023 to $12.1 billion by 2028, at a CAGR of 7.6% from 2023 to 2028.
Report Scope:
This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.
This report includes only human vaccines; animal vaccines have not been considered in this report.
This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.
The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.
Report Includes:
- 34 data tables and 63 additional tables
- An up-to-date overview of the global markets for vaccine technologies
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Estimate of the market size and revenue forecast for the global market, and a corresponding market share analysis based on technology, disease indication, age group and region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies, global R&D spending, and the regulatory landscape
- Assessment of present and future strategies in the innovation-driven vaccine technologies market, and a look at the vaccines for humans and their immunization schedule
- Discussion of the importance of ESG in the market for vaccine technologies, including consumer attitudes, the impact of ESG factors on company performance, and ESG practices of leading companies
- Review of patents and patent applications
- Overview of the major vendors, along with an analysis of the industry structure, including company market shares, recent M&A activity, and venture funding
- Analysis of the competitive landscape based on recent developments and segmental revenues
- Profiles of the leading companies
Table of Contents
Chapter 1 Introduction
- Study Background
- Study Goals and Objectives
- Reasons for Doing this Study
- Scope of Report
- What's New in This Update?
- Methodology
- Information Sources
- Geographic Breakdown
- Segmentation Breakdown
Chapter 2 Summary and Highlights
- Market Outlook
- Market Insights
Chapter 3 Market and Technology Background
- Definitions
- Immune System and Vaccines
- Components of the Immune System
- Cells of the Immune System
- Immune Response
- Major Histocompatibility Complex (MHC)
- Immunization and Vaccines
- Disorders of the Immune System
- Impact of Lifestyle on the Immune System
- How Vaccines Work
- Principles of Immunization
- Types of Immunity
- Advantages of Vaccination
- History of Vaccines
- Vaccines and Immunization, Overview
- Types of Vaccines
- Attenuated (Live) Vaccines
- Inactivated (Killed) Vaccines
- Toxoid Vaccines
- Subunit Vaccines
- Conjugate Vaccines
- Recombinant Vector Vaccines
- DNA Vaccines
- RNA Vaccines
- Immunization
- Advantages of Immunization
- Adjuvants and Excipients
- Pathogen Components
- Particulate Adjuvants
- Infectious Diseases Preventable by Vaccine
- Human Diseases
- Viral Diseases
- Bacterial Diseases
- Regulatory Aspects
- World Health Organization (WHO) Prequalified Vaccines
- New Product Approvals
- Recalls
- Significant Regulatory Developments in Vaccines
Chapter 4 Market Dynamics
- Overview
- Market Drivers
- Growing Awareness of Immunization
- Growing Investments and R&D
- New Vaccines
- Prevalence of Infectious Diseases
- Market Restraints
- Vaccine Development and Pricing
- Market Opportunities
- Increased Demand from Emerging Markets
- Therapeutic Vaccines
Chapter 5 Global Market for COVID-19 Vaccines
- Overview
- COVID-19 Vaccine Technologies
- Advent of mRNA Technology
- Impact of COVID-19 on Routine Infant Vaccination
- COVID-19 Disruptions
- Stagnating Global Coverage Rate
- Progress and Challenges by Country and Region
Chapter 6 Market Breakdown by Technology
- Global Market for Vaccine Technologies by Technology
- Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines
- Live-Attenuated Vaccines
- Inactivated Vaccines
- Toxoid Vaccines
- Other/Combination Vaccines
Chapter 7 Market Breakdown by Disease
- Global Market for Vaccine Technologies by Disease
- Pneumococcal
- Diphtheria and Tetanus
- HPV
- MMR
- Others
Chapter 8 Market Breakdown by Age Group
- Global Market for Vaccine Technologies by Age Group Treated
- Pediatrics
- Adolescents and Adults
Chapter 9 Market Breakdown by Region
- Global Market for Vaccine Technologies by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 10 Emerging Technologies and Developments
- Developments
- mRNA Vaccines
- Viral Vector Vaccines
- Nanoparticle Vaccines
- DNA Vaccines
- Virus-Like Particle (VLP) Vaccines
- Self-Amplifying RNA Vaccines
- Innovative Adjuvants
- AI and Computational Biology
- Personalized Vaccines
- Plant-Based Vaccines
Chapter 11 Competitive Landscape
- Competitive Landscape
- Company Share Analysis
Chapter 12 Company Profiles
- ABBOTT
- ASTRAZENECA
- BAVARIAN NORDIC
- BHARAT BIOTECH INTERNATIONAL LTD.
- EMERGENT BIOSOLUTIONS INC.
- GSK PLC.
- JOHNSON & JOHNSON SERVICES INC.
- MERCK & CO. INC.
- MITSUBISHI TANABE PHARMA CORP.
- PANACEA BIOTEC LTD.
- PFIZER INC.
- SANOFI
Chapter 13 Appendix: List of Acronyms
